Clinical & Experimental Immunology

Cover image for Vol. 182 Issue 3

Edited By: M. Peakman

Impact Factor: 3.037

ISI Journal Citation Reports © Ranking: 2014: 65/148 (Immunology)

Online ISSN: 1365-2249

Editorial Board

Meet the Editorial Team:


Professor M. Peakman
King's College London, UK

 Mark Peakman Mark Peakman is Professor of Clinical Immunology at King's College London, School of Medicine. He qualified in Medicine and then conducted PhD studies on the T cell autoimmune response in Type 1 diabetes, which has become his enduring research interest. He now oversees a research group in the Department of Immunobiology at King's, with a particular focus on defining the molecular targets of autoreactive T cells in autoimmune diseases, and using antigen-specific immune modulation in an attempt to combat the loss of tolerance that underlies these syndromes.

Associate Editors

Dr Danny Douek
National Institute of Allergy and Infectious Diseases/National Institutes of Health/DHHS, Bethesda, USA

 Danny Douek Danny Douek is Chief of the Human Immunology Section at the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases, NIH. He received his Medical Degree from the Universities of Oxford and London, and then a PhD in Immunology from the University of London. He is a widely published author in the field of human immunology and currently the main focus of his laboratory is the pathogenesis of HIV infection. 

Professor Angelo Manfredi
Università Vita Salute – San Raffaele Scientific Institute, Milano, Italy

 Angelo Manfredi Angelo Manfredi is Associate Professor of Rheumatology and Head of the Unit of Autoimmunity & Vascular Inflammation at the Università Vita Salute – San Raffaele Scientific Institute, Milano. He has been consistently working on the means by which intracellular antigens become immunogenic and on the mechanisms that have evolved to curb the initiation and persistence of inflammatory disease. 

Professor Xiao-Ning Xu
Imperial College, Chelsea and Westminster Hospital, London, UK

 Xiao-Ning Xu   Xiao-Ning Xu’s current research includes immune correlates of protection against emerging infectious diseases and vaccine development in humans; mainly focusing on HIV and influenza A infection. Xiao-Ning qualified in Medicine from Capital Medical University (Beijing) and obtained a PhD in Clinical Immunology from Flinders Medical Centre (Australia) and became a Fellow of the Royal College of Pathologists of Australasia (FRCPA). From 1995 to 2010 Xiao-Ning worked at Oxford University where he served as Senior Clinical Scientist and MRC Programme Leader at Weatherall Institute of Molecular Medicine. In 2010 he joined Novartis as the Head of Novartis Vaccines Research China, and in 2013 he moved to Imperial College London as a chair professor in Human Immunology and Head of Centre for Immunology and Vaccinology, based at Chelsea & Westminster Hospital.

Editorial Board

D. Barouch, Boston
R. Boyton, London
T. J. Braciale, Charlottesville
U. Christen, Frankfurt
J. Coleman, London
E. Y. Denkers, Ithaca
J. Dillner, Malmö
I. Dransfield, Edinburgh
J. C. W. Edwards, London
S. Fidler, London
A. Fischer, Paris
M. Goldman, Brussels
N. Haining, Boston
M. Herrmann, Erlangen
R. Hohlfeld, Munich
S. Jolles, Cardiff
J.C. Jensenius, Århus
H. Longhurst, London
M. Manns, Hannover
J. Milner, Bethesda
F. Nestle, London
P. Openshaw, London
R. Pujol-Borrell, Barcelona
I. Sabroe, Sheffield
F. P. Schena, Bari
W. Schwaeble, Leicester
J. Spencer, London
S. Sriskandan, London
P. Taylor, Cardiff
T. Tree, London
E. de Vries, ’s-Hertogenbosch
L. Walker, Birmingham

Editorial Office

Clinical & Experimental Immunology Editorial Office
The British Society for Immunology
Vintage House
37 Albert Embankment
United Kingdom

Tel: 44(0)20 3031 9817
Fax: 44 (0)20 7582 2882

All manuscripts submitted to Clinical and Experimental Immunology are peer-reviewed by two independent referees and also assessed by an editor prior to publication. Referees complete a standard evaluation form, as well as providing comments for the editors and authors, ensuring that the quality of manuscripts published in the Journal is maintained to a consistently high standard. Keywords aid in the selection of referees with appropriate expertise for each manuscript submitted.

The Journal is a member of the Committee on Publication Ethics (COPE) and authors submitting manuscripts to the journal are recommended to read the Guidelines on Good Publication Practice.

The Journal is also a member of the World Association of Medical Editors.